Chemistry Reference
In-Depth Information
Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H. and Kivipelto, M.,
2009. Midlife coffee and tea drinking and the risk of late-life dementia: a
population-based CAIDE study. J. Alzheimer's Dis. 16(1): 85-91.
Fredholm, B. B., B¨ ttig, K., Holm´n, J., Nehlig, A. and Zvartau, E. E., 1999.
Actions of caffeine in the brain with special reference to factors that
contribute to its widespread use. Pharmacol. Rev. 51(1): 83-133.
He, S. J., Xiao, C., Wu, Z. Y. and Ruan, D. Y., 2004. Caffeine-dependent
stimulus-triggered oscillations in the CA3 region of hippocampal slices
from rats chronically exposed to lead. Exp. Neurol. 190: 525-534.
Huang, C-H. , Chiang, Y-W. , Liang, K-C. , Thompson, R. F. and Liu, I. Y.,
2010. Extra-cellular signal-regulated kinase 1/2 (ERK1/2) activated in the
hippocampal CA1 neurons is critical for retrieval of auditory trace fear
memory. Brain. Res. 1326: 143-151.
Joghataie, M. T., Roghani, M., Negahdar, F. and Hashemi, L. 2004.
Protective effect of caffeine against neurodegeneration in a model of
Parkinson's
d n 0 t 2 n g | 7
disease
in
rat:
behavioral
and
histochemical
evidence.
Parkinsonism Relat. Disord. 10(8): 465-468.
Lindsay, J., Laurin, D., Verreault, R., H´bert, R., Helliwell, B., Hill, G.B. and
McDowell, I., 2002. Risk factors for Alzheimer's disease: a prospective
analysis from the Canadian Study of Health and Aging. Am. J. Epidemiol.
156(5): 445-453.
Lu, K. T., Wu, S. P., and Gean, P. W., 1999. Promotion of forskolin induced
long-term potentiation of synaptic transmission by caffeine in area CA1 of
the rat hippocampus. Chin. J. Physiol. 42: 249-253.
Lu, L., Koya, E., Zhai, H., Hope, B.T. and Shaham, Y., 2006. Role of ERK in
cocaine addiction. Trends Neurosci. 29(12): 695-703.
Maia, L. and de Mendon¸a, A., 2002. Does caffeine intake protect from
Alzheimer's disease? Eur. J. Neurol. 9(4): 377-382.
Malinauskas, B. M., Aeby, V. G., Overton, R. F. and Barber-Heidal, K., 2007.
A survey of energy drink consumption patterns among college students.
Nutr. J. 6(35): 1-7.
Nehlig, A., Armspach, J. P. and Namer, I. J., 2010. SPECT assessment of
brain
activation
induced
by
caffeine:
no
effect
on
areas
involved
in
dependence. Dialogues Clin. Neurosci. 12(2): 255-263.
Okada, M., Mizuno, K. and Kaneko, S., 1996. Adenosine A1 and A2 receptors
modulate extracellular dopamine levels in rat striatum. Neurosci. Lett.
212(1): 53-56.
Okada, M., Kawata, Y., Kiryu, K., Mizuno, K., Wada, K., Tasaki, H. and
Kaneko, S. 1997. Effects of adenosine receptor subtypes on hippocampal
extracellular serotonin level and serotonin reuptake activity. J Neurochem.
69(6): 2581-2588.
Ravina, B. M., Fagan, S. C., Hart, R. G., Hovinga, C. A., Murphy, D. D.,
Dawson, T. M. and Marler, J. R., 2003. Neuroprotective agents for clinical
trials in Parkinson's disease: a systematic assessment. Neurology. 60(8):
1234-1240.
 
Search WWH ::




Custom Search